Your session is about to expire
← Back to Search
Anti-bacterial Agent
Antibiotic Irrigation for Appendicitis (PA protocol Trial)
Phase 2
Waitlist Available
Led By Robert Gates, MD
Research Sponsored by Prisma Health-Upstate
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled to undergo laparoscopic appendectomy
Male or female, age 18 years or younger
Must not have
Not willing to provide written informed consent or undergo randomization of treatment
Declined to undergo laparoscopic appendectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group
All Individual Drugs Already Approved
Summary
This trial is testing if washing the surgical area with an antibiotic solution during appendix surgery helps prevent infections better than just using suction. It focuses on children with a burst appendix to see if this method reduces post-surgery infections.
Who is the study for?
This trial is for children and teenagers up to 18 years old who are scheduled for laparoscopic surgery due to perforated appendicitis. Participants must be willing to follow the treatment plan and come back for check-ups. Pregnant individuals or those not consenting to the study's procedures cannot join.
What is being tested?
The study is testing if rinsing out the appendix area with antibiotics (gentamicin/clindamycin) during surgery helps prevent infections better than just using suction without any rinse. Kids in this study will randomly get one of these two treatments.
What are the potential side effects?
Possible side effects may include reactions to the antibiotic solution, such as allergic responses or irritation at the site where surgery was done. The exact side effects will depend on how each child reacts to the antibiotic.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a laparoscopic surgery to remove my appendix.
Select...
I am 18 years old or younger.
Select...
My appendix was found to be ruptured before or during surgery.
Select...
My appendix was found to be ruptured before or during surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not willing to sign consent or be randomly assigned a treatment.
Select...
I have chosen not to have surgery to remove my appendix.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
wound complications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Antibiotic irrigation with suctionExperimental Treatment1 Intervention
Group A: You will receive antibiotic irrigation with suction if a PA is found during surgery
Group II: suction onlyActive Control1 Intervention
Group B: You will receive suction alone if a PA is found during surgery
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The primary treatment for appendicitis is surgical removal of the appendix (appendectomy), which can be performed via open surgery or laparoscopically. Antibiotic therapy is also crucial, especially in cases of perforated appendicitis, to prevent and treat infections.
Gentamicin and clindamycin are antibiotics used for their broad-spectrum activity against gram-negative and anaerobic bacteria, respectively. When used in local antibiotic irrigation during surgery, these antibiotics directly target the infected area, reducing bacterial load and preventing postoperative infections.
This localized approach minimizes systemic side effects and enhances the effectiveness of infection control, which is vital for improving patient outcomes and reducing complications in appendicitis treatment.
Find a Location
Who is running the clinical trial?
Prisma Health-UpstateLead Sponsor
86 Previous Clinical Trials
43,626 Total Patients Enrolled
Robert Gates, MDPrincipal InvestigatorPrisma Health
Share this study with friends
Copy Link
Messenger